Integrilin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Eptifibatide.
Product ID | 0085-1136_0b07e9e2-08a4-4b8f-a3d5-81dfe25f2031 |
NDC | 0085-1136 |
Product Type | Human Prescription Drug |
Proprietary Name | Integrilin |
Generic Name | Eptifibatide |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-08-18 |
Marketing Category | NDA / NDA |
Application Number | NDA020718 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | EPTIFIBATIDE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1998-05-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020718 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1998-05-18 |
Marketing Category | NDA |
Application Number | NDA020718 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-08-18 |
Marketing Category | NDA |
Application Number | NDA020718 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-01-23 |
Ingredient | Strength |
---|---|
EPTIFIBATIDE | .75 mg/mL |
SPL SET ID: | bd14390c-f3a1-4f19-a9d0-f137abfcddc0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0085-1136 | Integrilin | Eptifibatide |
0085-1177 | Integrilin | Eptifibatide |
0338-9558 | Eptifibatide | Eptifibatide |
0338-9559 | Eptifibatide | Eptifibatide |
0703-1165 | Eptifibatide | Eptifibatide |
14335-070 | Eptifibatide | eptifibatide |
14335-071 | Eptifibatide | eptifibatide |
16729-259 | EPTIFIBATIDE | Eptifibatide |
16729-260 | EPTIFIBATIDE | Eptifibatide |
17478-902 | Eptifibatide | Eptifibatide |
17478-903 | Eptifibatide | Eptifibatide |
25021-408 | eptifibatide | eptifibatide |
25021-409 | eptifibatide | eptifibatide |
52958-040 | Eptifibatide | Eptifibatide |
52958-402 | Eptifibatide | Eptifibatide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INTEGRILIN 75009658 2234543 Live/Registered |
MILLENNIUM PHARMACEUTICALS, INC. 1995-10-11 |